Sumitomo Pharma Co Ltd
Sumitomo Pharma's Climate Target Data Preview
As of 2023, Sumitomo Pharma has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Sumitomo Pharma ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 3 - Purchased Goods and Services (Cat. 1) | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Sumitomo Pharma's Greenhouse Gas Emissions Pathways
As of 2023, Sumitomo Pharma has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.
Does Sumitomo Pharma have a target to reduce the emissions from its operations?
As of 2023, Sumitomo Pharma has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.
Sumitomo Pharma's most ambitious operational target is to reduce these emissions by 42% by 2030, compared to a baseline of 72,519 Metric Tonnes of CO2 equivalent (mtCO2e) in 2020.
As of 2022, Sumitomo Pharma is ahead of schedule on its operational emissions reduction target, having achieved 59.52% of the planned reduction.